Skip to search formSkip to main contentSkip to account menu

Synagis

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Significance There is considerable interest in developing immunosuppressants that can specifically target effector memory T cells… 
2015
2015
Intramuscular injections are contra-indicated in infants with either acquired or congenital bleeding disorders. In such patients… 
2013
2013
The present invention has for its object a method for separating an antibody from a composition. In some embodiments, this method… 
2013
2013
1. A method for isolating Synagisiz composition comprising Synagis, the method comprising: i. carrying out an ion exchange… 
2012
2012
Objective: Determine factors affecting compliance in palivizumab use. Methods: Registry of infants who received >1 dose of… 
Review
2009
Review
2009
  • R. Giusti
  • Pediatric Pulmonology
  • 2009
  • Corpus ID: 5937001
Review
2002
Review
2002
Palivizumab (Synagis; Abbott Laboratories), a humanized, monoclonal antibody, prevents lower respiratory tract infection by… 
2001
2001
Respiratory Syncytial Virus (RSV) can be devastating to premature infants and children with chronic lung disease. Palivizumab… 
2000
2000
To the Editor. The continuing reports, letters, and pharmacoeconomic analyses concerning the use of expensive respiratory…